Aggressive Lymphoma
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers (NCT05020678) | Nkarta, Inc. | 2021-08-20 |
| Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia (NCT04806035) | TG Therapeutics, Inc. | 2021-04-28 |
| A Study Of The Selective PKC-β Inhibitor MS- 553 (NCT03492125) | MingSight Pharmaceuticals, Inc | 2018-05-25 |
| Rituximab and Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients With Aggressive B-cell Lymphoma (NCT01686321) | University of Göttingen | 2012-07-04 |
| Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL (NCT01562977) | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | 2011-04-01 |
Track Aggressive Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.